• No results found

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer

N/A
N/A
Protected

Academic year: 2020

Share "Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Consort diagram.
Table 2 Observational studies of sorafenib in RAi-R DTC from 2010–2013

References

Related documents

The aim of this study is to test the feasibility and accept- ability of the ICAN QUIT in Pregnancy intervention to increase health professionals' provision of evidence-

Comparison of these S1 sequences with those available in the GenBank revealed that they are 100% identical to some sequences isolated in the field which can be

We use data on 364 football players that were posted on the transfer market to study the effect of publicly announced reserve prices, and we identify both the reference point and

Some of the topics to be covered in this year’s conference include: the role of the anesthesiologist in an interdisciplinary team approach to enhanced recovery following

To estimate the drivers of more recent health care spending, the Centers for Medicare and Medicaid Services (CMS) Office of the Actuary used a model that considers the contribution

The data model allows one to (1) clearly distinguish factual information from questionable contents, (2) to represent all the aspects that characterise the latter as

Students with a Bachelor of Science degree in an engineering discipline, business, finance, accounting, management, or marketing must demonstrate proficiency in select

229 Testimony in Support of SB752, Relating to Domestic Violence Thank you for the opportunity to provide testimony in support of SB752 which would